Purchases and Sales Made in Q2 2023 in Vor Biopharma Inc. (VOR)
This table provides information about the institutional ownership of Vor Biopharma Inc. (VOR) during Q2 2023. The information is specifically focused on institutions that hold shares of Vor Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-51.5K- 55.21% |
$159K - $274K
|
41.8K
$58.5K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-57.5K- 66.1% |
$178K - $306K
|
29.5K
$41.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-97K- 75.84% |
$300K - $517K
|
30.9K
$43.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-105K- 3.75% |
$324K - $559K
|
2.69M
$3.76M
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-261K- 79.0% |
$808K - $1.39M
|
69.5K
$97.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-344K- 84.59% |
$1.06M - $1.83M
|
62.7K
$87.8K
|